Merck & Co., Inc. is a global research-driven pharmaceutical products company. Committed to bringing out the best in medicine
Contact usWorldwide
HomeAbout MerckProductsNewsroomInvestor InformationCareersResearchLicensingThe Merck Manuals

The Merck Manual--Second Home Edition logo
 
click here to go to the Index click here to go to the Table of Contents click here to go to the search page click here for purchasing information
Chapter 174. White Blood Cell Disorders
Topics: Introduction | Neutropenia | Neutrophilic Leukocytosis | Lymphocytopenia | Lymphocytic Leukocytosis | Monocyte Disorders | Eosinophilic Disorders | Basophilic Disorders
 
green line

Basophilic Disorders

Basophils account for less than 3% of the circulating leukocytes (0 to 300 basophils per microliter of blood). These cells have some role in immune surveillance and wound repair. Basophils can release histamine and other mediators and play a role in the initiation of allergic reactions. A decrease in the number of basophils (basopenia) can occur as a response to thyrotoxicosis, acute hypersensitivity reactions, and infections. An increase in the number of basophils (basophilia) can be seen in people with hypothyroidism. In the myeloproliferative disorders (for example, polycythemia vera and myelofibrosis), a marked increase in the number of basophils can occur.

Site MapPrivacy PolicyTerms of UseCopyright 1995-2004 Merck & Co., Inc.